Guidance for charities, other civil society organisations, researchers, research institutions and funders, to achieve successful research partnerships.

HRCI / PPI Ignite Network – Charities & Researchers Partnering Guide

This publication delves into the immense value that arises when charities and researchers partner to achieve societal benefit from research. The amalgamation of their distinct expertise and wisdom holds the potential to improve lives. However, despite the promise, there remains a lack of comprehensive guidance on how to navigate these partnerships effectively and address all relevant considerations.

This guide is the result of a collaborative effort between Health Research Charities Ireland (HRCI) and the PPI Ignite Network. We are grateful for the valuable input received from diverse individuals representing various roles within partnerships.

Acces this publication
Captura de pantalla 2026-05-14 092928

Year of publication

2026

Author

HRCI, PPI Ignite Network

You might also be interested in

ERDERA trainings template (9)

The 2027 Open Academy x ERDERA Schools is now open for application

Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.
ERDERA trainings template (9)

Open Academy x ERDERA Schools

June 7 - June 10
The Open Academy x ERDERA accompanies patient advocates by offering rare-disease specific comprehensive training programmes that empower advocates with the knowledge, skills and confidence they need to engage with different stakeholders as equal partners.
2

ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases

ERDERA (the European Rare Diseases Research Alliance) has opened its Clinical Trial Call to support multinational early-phase clinical trials in rare diseases. The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.
ECRD 2026

ECRD 2026 in Prague strengthens the push for a coordinated EU Action Plan on rare diseases

On 3–4 June, EURORDIS–Rare Diseases Europe and Orphanet convened the rare disease community at ECRD 2026 in Prague around a shared call for coordinated European action, including the forthcoming European Blueprint for Rare Diseases.

ERDERA Search